Geriatrik Nefroloji

EnglishTürkçe

BÖLÜM


DOI :10.26650/B/CH12CH47.2023.014.06   IUP :10.26650/B/CH12CH47.2023.014.06    Tam Metin (PDF)

Geri̇atri̇k Vakalarda Noktüri̇ Ve Noktürnal Poli̇üri̇

Sümeyra Koyuncu, Bülent Tokgöz

Yaşlanmayla birlikte üriner sistem anatomi ve işlevlerinde meydana gelen değişiklikler poliüri, noktüri ve noktürnal poliüri gibi işeme bozukluklarına yol açabilir. Poliüri, noktüri ve noktürnal poliüri iç-içe geçen kavramlardır. Tanım olarak poliüri, günlük idrar hacminin günde 40 ml/kg vücut ağırlığı veya 2800 ml’yi aşmasıdır. Normal fizyolojik koşullarda gece idrar miktarı azalması gerekirken, toplam idrar çıkışının %33’ünden fazlasının gece saatlerine denk gelmesine noktürnal poliüri denir. Gece uykusunun idrara çıkmak için birden çok kez bölünmesi noktüri olarak isimlendirilir.1 Yaşlılarda noktüri, mortalite ve morbiditede artışla ilişkili bulunmuştur.2,3 Yaşlılarda noktüriye ve noktürnal poliüriye yol açan sebepler, sırasıyla, Tablo 1 ve Tablo 2’de belirtilmiştir. Poliüri ve noktürnal poliürinin kesişim noktasında yer alan noktüri, halen en sık rastlanan alt üriner sistem semptomu olma özelliğini korumaktadır.4,5 Noktüri uyku kalitesinin bozulmasıyla birlikte depresyon oranlarında artış, fiziksel ve zihinsel sağlıkta bozulma ve yaş ilerledikçe düşme oranlarının artmasıyla birlikte kırık riskinin de artmasına neden olmaktadır.2,3 Genel olarak 60 yaş üstü kişilerde, 40-50 yaşlara göre 4 kat daha sık görülür. Erken yaşlarda kadınlarla daha sık görülürken, ilerleyen yaşlarda her iki cinste de sıklığı yükselir.6 Genç̧ kadınlarda noktüri sıklığı %4.4 -18 aralığındayken yaşlı kadınlarda bu oran %28.3-61.5 aralığındadır. Erkeklerdeyse, genç yaşlarda %2-16.6 ve yaş- lılarda %29-59.3 aralığında tespit edilmektedir.7



Referanslar

  • 1. Hashim H, Blanker MH, Drake MJ et al. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function. Neurourol Urodyn. 2019 Feb;38(2):499-508. Epub 2019 Jan 15. google scholar
  • 2. Vaughan CP, Brown CJ, Goode PS, Burgio KL, Allman RM, Johnson TM 2nd. The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract. 2010 Apr;64(5):577-83. google scholar
  • 3. Galizia G, Langellotto A, Cacciatore F, et al. Association between nocturia and falls-related longterm mortality risk in the elderly. J Am Med Dir Assoc. 2012 Sep;13(7):640-4. google scholar
  • 4. Pesonen JS, Cartwright R, Mangera A, et al. Incidence and remissionof nocturia: a systematic review and metaanalysis. Eur Urol.2016;70:372- 381. google scholar
  • 5. Welliver C, Sulaver R, Whittington A, et al. Analyzing why men seek treatment for lower urinary tract symptoms and factors associated with nonimprovement. Urology 2015; 86:862-867. google scholar
  • 6. Tikkinen KA, Tammela TL, Huhtala H, Auvinen A. Is nocturia equally common among men and women? A population based study in Finland. J Urol. 2006 Feb;175(2):596-600 google scholar
  • 7. Bosch JL, Weiss JP. The prevalence and causes of nocturia. J. Urol 2010; 184:440-446. google scholar
  • 8. Van Kerrebroeck P, Andersson KE. Terminology, epidemiology, etiology, and pathophysiology of nocturia. Neurourol Urodyn. 2014;33: Suppl 1: S2-S5. google scholar
  • 9. Wagg A, Cohen M. Medical therapy for the overactive bladder in the elderly. Age Ageing. 2002 Jul;31(4):241-6. google scholar
  • 10. Van Kerrebroeck P, Abrams P, Chaikin D, et al. Standardisation Subcommittee of the International Conti-nence Society. The standardisation of terminology in nocturia: report from the Standardisation Sub-com-mittee of the International Continence Society. Neurourol Urodyn. 2002;21(2):179-83 google scholar
  • 11. Weiss JP. Nocturia: focus on etiology and consequences. Rev Urol. 2012; 14:48. google scholar
  • 12. Asplund R, Aberg H. Diurnal variation in the levels of antidiuretic hormone in the elderly. J Intern Med. 1991 Feb;229(2):131-4 google scholar
  • 13. Varilla, V., Samala, R. V., Galindo, D., & Ciocon, J. (2011). Nocturia in the elderly: A wake-up call. Cle-veland Clinic Journal of Medicine, 78(11), 757-764. google scholar
  • 14. Pfisterer MH, Griffiths DJ, Schaefer W, Resnick NM. The effect of age on lower urinary tract function: a study in women. J Am Geriatr Soc. 2006 Mar;54(3):405-12 google scholar
  • 15. Fitzgerald MP, Mulligan M, Parthasarathy S. Nocturic frequency is related to severity of obstructive sleep apnea, improves with continuous positive airways treatment. Am J Obstet Gynecol. 2006 May;194(5):1399-403. google scholar
  • 16. Oelke M, Adler E, Marschall-Kehrel D, Herrmann TR, Berges R. Nocturia: state of the artand critical analysis of current assessment and treatment strategies.World J Urol. 2014; 32:1109-1117 google scholar
  • 17. Teunissen TA, de Jonge A, van Weel C, Lagro-Janssen AL. Treating urinary incontinence in the elderly conservative therapies that work: a systematic review. J Fam Pract. 2004 Jan;53(1):25-30, 32. google scholar
  • 18. Burgio KL, Goode PS, Johnson TM, et al. Behavioral versus drug treatment for overactive bladder in men: the Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial. J Am Geriatr Soc. 2011 Dec;59(12):2209-16 google scholar
  • 19. Cohn JA, Kowalik CG, Reynolds WS, et al. Desmopressin acetate nasal spray for adults with nocturia. Expert Rev Clin Pharmacol. 2017; 10:1281-1293. google scholar
  • 20. Juul KV, Malmberg A, van der Meulen E, Walle JV, N0rgaard JP. Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia. BJU Int. 2017; 119:776-784 google scholar
  • 21. Yamaguchi O, Nishizawa O, Juul KV, Norgaard JP. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo controlled trial. BJU Int. 2013; 111:474-484. google scholar
  • 22. Pedersen PA, Johansen PB. Prophylactic treatment of adult nocturia with bumetanide. Br J Urol. 1988; 62:145-7. google scholar
  • 23. Reynard JM, Cannon A, Yang Q, Abrams P. A novel therapy for nocturnal polyuria: a double-blind rando-mized trial of frusemide against placebo. Br J Urol. 1998; 81:215-8. google scholar
  • 24. Fu FG, Lavery HJ, Wu DL. Eurourol Urodyn. Reducing nocturia in the elderly: a randomized placebo-cont-rolled trial of staggered furosemide and desmopressin.2011;30:312-6. google scholar
  • 25. Addla SK, Adeyoju AB, Neilson D, O’Reilly P. Diclofenac for treatment of nocturia caused by nocturnal polyuria: a prospective, randomised, double-blind, placebo-controlled crossover study. Eur Urol. 2006; 49:720-5. google scholar
  • 26. Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebocontrolled study.Urology. 2008; 72:813-6. google scholar
  • 27. De Mey C, Michel MC, McEwen J, Moreland T. A double-blind comparison of terazosin and tamsulosin on their differential effects on ambulatory blood pressure and nocturnal orthostatic stress testing. Eur Urol. 1998;33(5):481-8 google scholar
  • 28. Roehrborn CG, Van Kerrebroeck P, Nordling J. Safety and efficacy of alfuzosin 10 mg once-daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double-blind, placebo-controlled studies. BJU Int. 2003 Aug;92(3):257-61 google scholar
  • 29. Kelleher C, Hakimi Z, Zur R, et al. Efficacy and Tolerability of Mirabegron Compared with Antimuscari-nic Monotherapy or Combination Therapies for Overactive Bladder: A Systematic Review and Network Meta-analysis. Eur Urol. 2018 Sep;74(3):324-333 google scholar
  • 30. Hassouna MM, Siegel SW, Ny eholt AA, Elhilali MM, van Kerrebroeck PE, Das AK, Gajewski JB, Jankne-gt RA, Rivas DA Dijkema H, Milam DF, Oleson KA, Schmidt RA: Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol 163: 1849 -1854, 2000) google scholar
  • 31. Drake MJ, Mills IW, Noble JG. Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement. J Urol 2004;171(3):1199. google scholar


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.